Viewing Study NCT05105412


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2025-12-26 @ 10:46 PM
Study NCT ID: NCT05105412
Status: TERMINATED
Last Update Posted: 2024-07-08
First Post: 2021-10-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas
Sponsor: National Health Research Institutes, Taiwan
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module